✦ LIBER ✦

Comparison of the Effect of Bezafibrate on Improvement of Atherogenic Lipoproteins in Japanese Familial Combined Hyperlipidemic Patients With or Without Impaired Glucose Tolerance

✍ Scribed by Kozo Hayashi; Hitoshi Kurushima; Yoshio Kuga; Tetsuji Shingu; Kouichi Tanaka; Yuji Yasunobu; Katsuhiko Nomura; Harumi Ohtani; Takaki Hiraga; Yasushi Toyota; Takahiro Katano; Kazuko Sakai-Ohta; Goro Kajiyama

Book ID: 110254600
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 217 KB
Volume: 12
Category: Article
ISSN: 0920-3206
DOI: 10.1023/a:1007781310827

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2.P.39 Effect of bezafibrate on atheroge

2.P.39 Effect of bezafibrate on atherogenic lipoproteins in Japanese familial combined hyperlipidemic patients with or without impaired glucose tolerance

✍ Kozo Hayashi; Yoshio Kuga; Tetsuji Shingu; Kouichi Tanaka; Yuji Yasunobu; Katsuh 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 364 KB

Effect of rosiglitazone on the frequency

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 131 KB

Long-term effect of simvastatin on the i

Long-term effect of simvastatin on the improvement of impaired myocardial flow reserve in patients with familial hypercholesterolemia without gender variance

✍ Ikuo Yokoyama; Katsunori Yonekura; Yusuke Inoue; Kuni Ohtomo; Ryozo Nagai 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 98 KB

A 52-Week, Randomized, Open-Label, Paral

A 52-Week, Randomized, Open-Label, Parallel-Group Comparison of the Tolerability and Effects of Pitavastatin and Atorvastatin on High-Density Lipoprotein Cholesterol Levels and Glucose Metabolism in Japanese Patients with Elevated Levels of Low-Density Lipoprotein Cholesterol and Glucose Intolerance

✍ Jun Sasaki; Yoshihiko Ikeda; Tadanobu Kuribayashi; Keizou Kajiwara; Sadatoshi Bi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Effects of the New Dual PPAR / Agonist G

Effects of the New Dual PPAR / Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism

✍ Cariou, B.; Zair, Y.; Staels, B.; Bruckert, E. 📂 Article 📅 2011 🏛 American Diabetes Association 🌐 English ⚖ 733 KB

Comparison of effects of bezafibrate and

Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study

✍ Tohru Noguchi; Junji Kobayashi; Kunimasa Yagi; Atsushi Nohara; Naoto Yamaaki; Ma 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 165 KB